[18F]Tetrafluoroborate

N/A

Report date: 2022/11/14 10:43:53
NME

Base Information

Drug Name[18F]Tetrafluoroborate
Drug Alias NameTFBBF4[18F]-TFB[18F]TFB18F-TFB
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsEndometrial NeoplasmsBone Marrow Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMayo Clinic
Active IndicationsN/A
Inactive IndicationsEndometrial NeoplasmsBone Marrow Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A